The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Migraine Frequency at 12 Weeks
Timeframe: Baseline and 12 weeks
Frequency of Adverse Event
Timeframe: 26 weeks